Moderna Inc
(MIL:1MRNA)
€
38.165
-0.445 (-1.15%)
Market Cap: 14.61 Bil
Enterprise Value: 9.32 Bil
PE Ratio: 0
PB Ratio: 1.30
GF Score: 44/100 Moderna Inc at Cowen Health Care Conference (Virtual) Transcript
Mar 09, 2022 / 02:10PM GMT
Tyler Martin Van Buren
Cowen and Company, LLC, Research Division - Analyst
Good morning, everyone. Welcome to the third day of Cowen's 42nd Annual Healthcare Conference. My name is Tyler Van Buren. I'm a senior biotech analyst here at Cowen. For this next session, we have a fireside chat with Moderna. It is my pleasure to introduce Stephane Bancel, the Chief Executive Officer.
Stephane, it's a privilege to have you. Thank you very much for being here.
Stephane Bancel
Moderna, Inc. - CEO & Director
Thank you, Tyler, for having us.
Questions & Answers
Tyler Martin Van Buren;Stephane Bancel
Cowen and Company, LLC, Research Division - Analyst;Moderna, Inc. - CEO & Director<
Of course. (Operator Instructions) And so first, I'd like to start with a couple of general questions before I get -- Stephane, before we get into COVID and the pipeline. First one is, in 2030, what percentage of your business do you foresee being in therapeutics as opposed to vaccines?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot